This integrative analysis provided a potential signaling axis in which bone-secreted soluble factors regulate tumoral PKA, which, in turn, regulates PPARA, VDR, SLC16A1, GPX1 and PAPSS2 expression, leading to the metabolic rewiring of PCa cells, likely favoring disease progression. The gene discussed is GPX1; the disease is posterior cortical atrophy.